SAN DIEGO, Dec. 5 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated announced today that it will webcast its meeting with financial analysts in New York on Tuesday, December 12, 2006, at 1:00 p.m. Eastern time. The event will feature presentations on Gen-Probe's current business and future growth strategies by company executives including Henry L. Nordhoff, chairman, president and chief executive officer; Dan Kacian, executive vice president and chief scientist; Steve Kondor, vice president, sales and marketing; Larry Mimms, executive vice president, research and development; Linda Merrill, vice president, industrial relationships; Harry Rittenhouse, senior director, cancer diagnostics; and Herm Rosenman, vice president, finance and chief financial officer.
The meeting and webcast will conclude at approximately 4:30 p.m. The live webcast may be accessed on the investment information section of the Company's web site at www.gen-probe.com. A replay of the webcast will be available on the same web site for 30 days following the event.
About Gen-Probe
Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 20 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 900 people. For more information, go to www.gen-probe.com.
Caution Regarding Forward-Looking Statements
Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. For information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including the Form 10-Q for the quarter ended September 30, 2006, and all subsequent periodic filings made with the SEC. We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.
Contact: Paula Izidoro Investor Relations 858-410-8904
Gen-Probe IncorporatedCONTACT: Investor Relations, Paula Izidoro of Gen-Probe Incorporated,+1-858-410-8904
Web site: http://www.gen-probe.com/
